Literature DB >> 29965849

What is new in paediatric uveitis?

Kara C LaMattina1, Anjum F Koreishi2.   

Abstract

PURPOSE OF REVIEW: The aim of this study was to summarize the demographics and causes of paediatric uveitis and to discuss the latest treatment options for noninfectious paediatric uveitis. RECENT
FINDINGS: In the last few years, reports out of Europe, Asia and the Americas have shown that the causes of paediatric uveitis can vary greatly geographically. With ongoing research into therapeutics, particularly the development of biologic agents, the treatment of noninfectious entities has evolved over time.
SUMMARY: Epidemiology data show that most paediatric uveitis cases worldwide are chronic and have noninfectious causes. Fortunately, we have more treatment options than ever to combat these sight-threatening diseases.

Entities:  

Mesh:

Year:  2018        PMID: 29965849     DOI: 10.1097/ICU.0000000000000501

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  4 in total

1.  Pediatric Noninfectious Uveitis in a Tertiary Referral Center in Jordan: Clinical Spectrum and Immunomodulatory Treatment.

Authors:  Raed Alzyoud; Motasem Alsuwaiti; Hiba Maittah; Boshra Aladaileh; Mohammed Nobani; Ayman Farhan; Hadeel Alqurieny; Ahmed Khatatbeh; Zeyad Habahbeh
Journal:  Cureus       Date:  2022-06-11

Review 2.  Paediatric autoimmune and autoinflammatory conditions associated with uveitis.

Authors:  Najiha Rahman; Harry Petrushkin; Ameenat Lola Solebo
Journal:  Ther Adv Ophthalmol       Date:  2020-11-02

3.  Tubercular subretinal abscess in a pediatric intermediate uveitis patient on methotrexate.

Authors:  Nivedita Nair; S Sudharshan; M Ram Prakash; Vikas Khetan; Chetan Rao
Journal:  Indian J Ophthalmol       Date:  2020-09       Impact factor: 1.848

4.  Simultaneous presentation of idiopathic uveitis in monozygotic 4-year-old twin boys.

Authors:  Sarah Baxter; Russell N Van Gelder; Jason C Cheung; Matthew L Basiaga
Journal:  Am J Ophthalmol Case Rep       Date:  2022-07-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.